Rivanicline
Alternative Names: Research programme: ulcerative colitis therapy - Dr Falk Pharma/Targacept; TC 2403-12; TC-2403; Ulcerative colitis therapy research programme - Targacept/Dr Falk PharmaLatest Information Update: 13 Dec 2007
At a glance
- Originator Targacept
- Developer Dr Falk Pharma; Targacept
- Class Neuroprotectants; Nootropics; Pyridines; Small molecules; Solanaceous alkaloids
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ulcerative colitis